Patents by Inventor Rikard Emond

Rikard Emond has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150239905
    Abstract: The invention relates to compounds of formula (I): and their pharmaceutically acceptable salts and solvates, which are inhibitors of SSAO activity. The invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the treatment or prevention of medical conditions wherein inhibition of SSAO activity is beneficial, such as inflammatory diseases and immune disorders.
    Type: Application
    Filed: May 14, 2015
    Publication date: August 27, 2015
    Inventors: Marianne Nilsson, Martin Haraldsson, Sofia Henriksson, Rikard Emond, Edward Savory, Iain Simpson
  • Publication number: 20140206662
    Abstract: A method of treating inflammation, an inflammatory disease, an immune or an autoimmune disorder comprising administering to a patient in need thereof compounds of formula (I): and their pharmaceutically acceptable salts and solvates, which are inhibitors of SSAO activity. The compounds inhibit SSAO activity.
    Type: Application
    Filed: March 13, 2014
    Publication date: July 24, 2014
    Applicant: PROXIMAGEN LTD.
    Inventors: Marianne Nilsson, Martin Haraldsson, Sofia Henriksson, Rikard Emond, Edward Savory, Iain Simpson
  • Publication number: 20120010188
    Abstract: The invention relates to compounds of formula (I): and their pharmaceutically acceptable salts and solvates, which are inhibitors of SSAO activity. The invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the treatment or prevention of medical conditions wherein inhibition of SSAO activity is beneficial, such as inflammatory diseases and immune disorders.
    Type: Application
    Filed: December 4, 2009
    Publication date: January 12, 2012
    Applicant: PROMIMAGEN LTD.
    Inventors: Marianne Nilsson, Martin Haraldsson, Sofia Henriksson, Rikard Emond, Edward Daniel Savory, Iain David Simpson
  • Publication number: 20100113435
    Abstract: The present invention relates to compounds with the formula (II) and also to pharmaceutical compositions comprising the compounds, to processes for their preparation, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-?-hydroxysteroid dehydrogenase type 1 enzyme.
    Type: Application
    Filed: November 16, 2009
    Publication date: May 6, 2010
    Inventors: Tjeerd BARF, Rikard Emond, Guido Kurz, Jerk Vallgarda, Marianne Nilsson
  • Patent number: 7671051
    Abstract: The present invention relates to compounds with the formula (I) and also to pharmaceutical compositions comprising the compounds, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-?-hydroxysteroid dehydrogenase type 1 enzyme.
    Type: Grant
    Filed: July 13, 2005
    Date of Patent: March 2, 2010
    Assignee: Biovitrum AB
    Inventors: Tjeerd Barf, Rikard Emond, Jerk Vallgarda, Guido Kurz, Marianne Nilsson, Lian Zhang
  • Patent number: 7618961
    Abstract: The present invention relates to compounds with the formula (II) and also to pharmaceutical compositions comprising the compounds, to processes for their preparation, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-?-hydroxysteroid dehydrogenase type 1 enzyme.
    Type: Grant
    Filed: May 22, 2001
    Date of Patent: November 17, 2009
    Assignee: Biovitrum AB
    Inventors: Tjeerd Barf, Rikard Emond, Guido Kurz, Jerk VallgÄrda, Marianne Nilsson
  • Publication number: 20080103123
    Abstract: The present invention relates to compounds of Formula (Ia) and pharmaceutically acceptable salts, hydrates, geometrical isomers, racemates, tautomers, optical isomers and N-oxides thereof, wherein one of W1 and W2 is N and the other is CR12. The invention also relates to pharmaceutical compositions comprising these compounds, and to the use of these compounds for the prophylaxis and treatment of medical conditions relating to disorders of the G-protein-coupled receptor GPR119, such as diabetes and obesity.
    Type: Application
    Filed: August 29, 2007
    Publication date: May 1, 2008
    Applicant: Biovitrum
    Inventors: Peter Brandt, Rikard Emond, Gary Johansson, Lars Johansson, Tobias Koolmeister, Bjorn Nilsson, Teresa Sandvall, Michael Weber
  • Patent number: 7094792
    Abstract: The present invention relates to compounds with the formula (I) and also to pharmaceutical compositions comprising the compounds, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-?-hydroxysteroid dehydrogenase type 1 enzyme.
    Type: Grant
    Filed: November 22, 2002
    Date of Patent: August 22, 2006
    Assignee: Biovitrum AB
    Inventors: Tjeerd Barf, Rikard Emond, Guido Kurz, Marianne Nilsson, Jerk VallgÄrda, Lian Zhang
  • Publication number: 20050250776
    Abstract: The present invention relates to compounds with the formula (I) and also to pharmaceutical compositions comprising the compounds, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-?-hydroxysteroid dehydrogenase type 1 enzyme.
    Type: Application
    Filed: July 13, 2005
    Publication date: November 10, 2005
    Inventors: Tjeerd Barf, Rikard Emond, Guido Kurz, Marianne Nilsson, Jerk Vallgarda, Lian Zhang
  • Publication number: 20040224996
    Abstract: The present invention relates to compounds with the formula (II) and also to pharmaceutical compositions comprising the compounds, to processes for their preparation, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-&bgr;-hydroxysteroid dehydrogenase type 1 enzyme.
    Type: Application
    Filed: February 18, 2003
    Publication date: November 11, 2004
    Inventors: Tjeerd Barf, Rikard Emond, Guido Kurz, Jerk Vallgarda, Marianne Nilsson
  • Publication number: 20030130318
    Abstract: The present invention relates to compounds with the formula (I) 1
    Type: Application
    Filed: November 22, 2002
    Publication date: July 10, 2003
    Inventors: Tjeerd Barf, Rikard Emond, Guido Kurz, Marianne Nilsson, Jerk Vallgarda, Lian Zhang
  • Patent number: 6313132
    Abstract: The invention relates to novel compounds of Formula (I) wherein R1, R2, R3, R4, R5, R6, R7 and Ar are as defined in claim 1, their salts with physiologically acceptable acids and, when the compounds can be in the form of optical isomers, the racemic mixture and the individual enantiomers. The compounds have anticholinergic activity, and the invention also relates to the compounds of Formula (I), the use of the compounds of Formula (I) for preparing anticholinergic drugs, the use of the compounds of Formula (I) for treating urinary tract incontinence, and methods for preparing the compounds of Formula (I).
    Type: Grant
    Filed: September 27, 1999
    Date of Patent: November 6, 2001
    Assignee: Pharmacia AB
    Inventors: Rolf Johansson, Martin Haraldsson, Erik Ringberg, Ian Vagberg, Katarina Beierlein, Rikard Emond, Birger Sjoberg